While contradictory effects on ROS production of ectopic KRAS have been reported, it may be certain that mutated-KRAS exquisitely mediates mitochondrial function and regulates the expression levels of ROS, particularly in pancreatic cancers. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.